Øystein Rekdal (CSO) and Baldur Sveinbjørnsson (Director Scientific Research) will attend the Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference in Mainz/Frankfurt September 6-9 2017, and on September 8th they will present the following two posters:

«LTX-315: A first-in- class oncolytic peptide that reshapes the tumor microenvironment”
Posternr B237, Session: Tumor microenvironment and its Modulation.

And

“LTX-315: A first-in- class oncolytic peptide that reshapes the tumor microenvironment- Results from an ongoing clinical phase I study”
Posternr B161, Session: Clinical Trials of Cancer Immunotherapies.

More information about the conference